| Drug-development economics | Company estimate |
| Typical drug-development program | $340M |
| Risk-adjusted failure cost | $79M |
| Liver toxicity failure rate | 5% |
| Expected liver-toxicity cost per program | $3.7M |
| VivoSim liver testing service | $25K–$50K |
| Drug-development economics | Company estimate |
| Typical drug-development program | $340M |
| Risk-adjusted failure cost | $79M |
| Liver toxicity failure rate | 5% |
| Expected liver-toxicity cost per program | $3.7M |
| VivoSim liver testing service | $25K–$50K |